Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | ICICI Pru |
| NAV | ₹666.3420 | ₹10.5300 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 13.9 years | 1.1 years |
| Expense ratio | 1.0% | 1.4% |
| Stars | ★★★★★ | Not rated |
| Growth Score | 75.20 | — |
Returns
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| 1 month | +11.40% | +8.22% |
| 3 months | +3.74% | −1.13% |
| 6 months | +8.55% | +5.83% |
| YTD | +16.94% | +4.46% |
| 1 year | +15.26% | +5.41% |
| 3 years (CAGR) | +17.96% | — |
| 5 years (CAGR) | +15.40% | — |
| 10 years (CAGR) | +16.61% | — |
| Since launch | +17.63% | +4.87% |
Risk
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Volatility | 14.1% | — |
| Downside volatility | 9.0% | — |
| Sharpe | 0.81 | — |
| Sortino | 1.28 | — |
| Calmar | 1.22 | — |
| Return / risk | 1.27 | — |
| Deepest fall | −24.02% | −14.08% |
| Days to recover | 445 | 45 |
| Below its high | +0.00% | −2.59% |
Against benchmark
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Alpha | −1.86% | — |
| Beta | 0.89 | — |
| R² | 89.5% | — |
| Up capture | 85.2% | — |
| Down capture | 88.7% | — |
| Tracking error | 4.8% | — |
| Information ratio | −0.69 | — |
| Treynor | 0.12 | — |
Consistency
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Best 1-year | +90.70% | — |
| Middle 1-year | +13.13% | — |
| Worst 1-year | −15.12% | — |
| 1-year periods with a loss | 23.2% | — |
| Middle 3-year | +19.82% | — |
| Positive months | 63.9% | — |
| Best day | +3.40% | +5.09% |
| Worst day | −3.21% | −3.88% |
| Worst 5% day | −1.38% | −1.76% |
| Positive days | 53.7% | 51.9% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| 5-year XIRR | +18.24% | — |
| 5-year value | ₹9,54,076 | — |
| 3-year XIRR | +14.26% | — |
| 1-year XIRR | +22.08% | +9.04% |
Holdings overlap i
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Nippon India Pharma Fund | — | 3% |
| ICICI Prudential Conglomerate Fund | 3% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund |
|---|---|---|
| Piramal Pharma Limited | 2.61% | 2.89% |
Sectors and company size
| Nippon India Pharma Fund | ICICI Prudential Conglomerate Fund | |
|---|---|---|
| Large companies | 29.6% | 64.5% |
| Mid companies | 40.8% | 16.8% |
| Small companies | 28.7% | 14.9% |
| Top 10 holdings | 57.2% | 50.3% |
| Largest sector | Pharmaceuticals & Biotechnology 75% | Automobiles 15% |